The MET/multikinase inhibitor cabozantinib blocked neuroblastoma cell proliferation and migration and efficiently reduced in vivo neuroblastoma tumor growth and metastases in orthotopic xenograft mouse models [158]. Here, MET is linked to neuroblastoma.